Person Closely Associated Dealing

Oxford, UK - 27 June 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the Company"), a quality and innovation-led cell and gene therapy CDMO, today announces that Pippa Radcliffe, a person closely associated with Kyriacos Mitrophanous, Chief Innovation Officer of the Company, exercised 839 options at nil cost and disposed 274 shares at £3 per share on 25 June 2024.

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, give further details of the transaction.

• Details of the Person Closely Associated ("PCA")
• Name P ippa Radcliffe
• Reason for the notification
• Position/status This notification concerns P ippa Radcliffe in her capacity as a person closely associated with a person discharging managerial responsibilities. The person discharging managerial responsibilities is Kyriacos Mitrophanous, Chief Innovation Officer o f the Company. The association arises by virtue of Pippa Radcliffe being the spouse of Kyriacos Mitrophanous .
• Initial notification/ amendment Initial Notification/Amendment
• Details of the Issuer
• Name Oxford Biomedica plc
• LEI code 213800S1GVQNXQ15K851
• Description of the financial instrument Identification code Ordinary Shares of 50 pence each ISIN: GB00BDFBVT43
• Nature of the transaction Exercise of Options at nil cost
• Currency GBP - British pound
• Price(s) and volumes(s) Price(s) Volume(s) Nil 839
• Aggregated information - Aggregate volume - Price - Aggregated total 839 NIL NIL
• Date of the transaction 2024-06-25
• Place of the transaction London Stock Exchange, Main Market (XLON)
• Name P ippa Radcliffe
• Reason for the notification
• Position/status This notification concerns P ippa Radcliffe in her capacity as a person closely associated with a person discharging managerial responsibilities. The person discharging managerial responsibilities is Kyriacos Mitrophanous, Chief Innovation Officer o f the Company. The association arises by virtue of Pippa Radcliffe being the spouse of Kyriacos Mitrophanous .
• Initial notification/ amendment Initial Notification
• Details of the Issuer
• Name Oxford BioMedica plc
• LEI code 213800S1GVQNXQ15K851
• Description of the financial instrument Identification code Ordinary Shares of 50 pence each ISIN: GB00BDFBVT43
• Nature of the transaction Disposal
• Currency GBP - British pound
• Price(s) and volumes(s) Price(s) Volume(s) £3 274
• Aggregated information - Aggregate volume - Price - Aggregated total 274 £3 £822.00
• Date of the transaction 2024-06-25
• Place of the transaction London Stock Exchange, Main Market (XLON)